Key result
Reduced SDNN predicts unfavorable 90-day functional outcomes after intravenous thrombolysis for acute ischemic stroke.
Why the study?
Few studies have evaluated autonomic nervous system function via heart rate variability in patients undergoing intravenous thrombolysis, and no HRV parameter had been conclusively established as an independent predictor of unfavorable prognosis.
Does lower standard deviation of normal-to-normal intervals (SDNN) predict unfavorable 90-day functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis?
Observational (n=150)
No
Does lower standard deviation of normal-to-normal intervals (SDNN) predict unfavorable 90-day functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis?
Impaired autonomic nervous system function, specifically reduced SDNN, is an independent predictor of 90-day disability in acute ischemic stroke patients treated with intravenous thrombolysis.
Answers are grounded in this paper and cite their sources.
May refine post-thrombolysis risk stratification via SDNN; leaves open whether autonomic interventions improve outcomes.
Background Recent studies have clarified the relationship between autonomic dysfunction and ischemic stroke location, etiology, and neurological outcomes. However, few studies have evaluated autonomic nervous system (ANS) function via heart rate variability (HRV) in patients undergoing intravenous thrombolysis. Moreover no HRV parameter has been conclusively established as an independent predictor of unfavorable prognosis in this clinical population. Methods We retrospectively analyzed data from acute ischemic stroke (AIS) patients treated with intravenous thrombolysis (IVT) between January 2021 and December 2023. HRV measurements were obtained within 7 days post-stroke to evaluate ANS function. Of the 150 patients included, a unfavorable outcome was defined as a modified Rankin Scale score >2 at 90-days. Multivariate logistic regression adjusted for potential confounders, was used to evaluate associations between HRV parameters and functional outcomes. Results Linear regression analyses revealed consistent associations between favorable functional outcomes and HRV parameters reflectiving both sympathetic and parasympathetic activity, assessed at 7- and 90-days post-stroke (all p < 0.05). In multivariable logistic regression model, a lower standard deviation of normal-to-normal intervals was identified as an independent Influencing factor of worse modified Rankin Scale scores after adjustment for potential confounders. Conclusion Impaired autonomic nervous system function in the acute phase of ischemic stroke may exert a sustained influence on recovery, extending to 90 days post-onset. Standard deviation of normal-to-normal intervals emerged as an independent risk factor for unfavorable prognosis in acute ischemic stroke patients treated with intravenous thrombolysis.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) conducted an observational in Adults with acute ischemic stroke treated with intravenous thrombolysis within 4.5 hours of symptom onset (n=150). Intravenous thrombolysis with alteplase (rt-PA) was evaluated on Unfavorable outcome defined as modified Rankin Scale score > 2 at 90 days (SDNN independently associated with unfavorable outcome, β=0.024, p=0.010 (adjusted model), p=<0.05). Reduced SDNN independently predicted 90-day unfavorable functional outcome after intravenous thrombolysis in acute ischemic stroke patients, with β=0.024 after adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: